Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Angiosarcoma”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Study completedNCT00217607
What this trial is testing

Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery

Who this might be right for
Sarcoma
UNICANCER 30
Testing effectiveness (Phase 2)Ended earlyNCT05026736
What this trial is testing

Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study

Who this might be right for
Locally Advanced AngiosarcomaMetastatic AngiosarcomaRecurrent Angiosarcoma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00041236
What this trial is testing

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 39
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Testing effectiveness (Phase 2)Active Not RecruitingNCT04668300
What this trial is testing

Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma

Who this might be right for
Metastatic AngiosarcomaMetastatic Dedifferentiated LiposarcomaMetastatic Osteosarcoma+5 more
M.D. Anderson Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT01614795
What this trial is testing

Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma

Who this might be right for
Childhood Alveolar Soft Part SarcomaChildhood AngiosarcomaChildhood Epithelioid Sarcoma+12 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)UnknownNCT00410462
What this trial is testing

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Ovarian CancerSarcomaSmall Intestine Cancer
European Organisation for Research and Treatment of Cancer - EORTC 118
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Testing effectiveness (Phase 2)Study completedNCT00526149
What this trial is testing

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Who this might be right for
Breast CancerEndometrial CancerHead and Neck Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 76
Not applicableStudy completedNCT01567046
What this trial is testing

Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas

Who this might be right for
Childhood Alveolar Soft-part SarcomaChildhood AngiosarcomaChildhood Desmoplastic Small Round Cell Tumor+12 more
Children's Oncology Group 70
Testing effectiveness (Phase 2)UnknownNCT00003718
What this trial is testing

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerOvarian CancerSarcoma
Herbert Irving Comprehensive Cancer Center 25
Large-scale testing (Phase 3)Study completedNCT00003052
What this trial is testing

Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 340
Testing effectiveness (Phase 2)Study completedNCT02048722
What this trial is testing

Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma

Who this might be right for
Adult AngiosarcomaRecurrent Adult Soft Tissue SarcomaStage III Adult Soft Tissue Sarcoma+1 more
Northwestern University 31
Testing effectiveness (Phase 2)Study completedNCT01623869
What this trial is testing

Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery

Who this might be right for
Adult AngiosarcomaRecurrent Adult Soft Tissue SarcomaStage III Adult Soft Tissue Sarcoma+1 more
National Cancer Institute (NCI) 16
Large-scale testing (Phase 3)Study completedNCT00003212
What this trial is testing

Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 780
Testing effectiveness (Phase 2)Study completedNCT00245102
What this trial is testing

Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Epithelioid SarcomaAdult Leiomyosarcoma+12 more
National Cancer Institute (NCI) 147
Testing effectiveness (Phase 2)Study completedNCT00031915
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00288015
What this trial is testing

Bevacizumab in Treating Patients With Angiosarcoma

Who this might be right for
Sarcoma
Northwestern University 32
Not applicableUnknownNCT00900211
What this trial is testing

Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX

Who this might be right for
Sarcoma
The Christie NHS Foundation Trust 400
Testing effectiveness (Phase 2)Study completedNCT00003939
What this trial is testing

Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Brain and Central Nervous System TumorsEndometrial CancerGastrointestinal Stromal Tumor+3 more
European Organisation for Research and Treatment of Cancer - EORTC 132
Load More Results